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ABSTRACT 
Shalakya Tantra is one of the eight specialties of Ashtanga Ayurveda which deals with diseases occur above 
the clavicle specially related to the sensory organs. Eyes hold special status among all the sense organs 
because good vision is crucial for social and intellectual development of human beings. Hence authentic 
classics prescribed several preventive and curative measures for the management of ophthalmic disorders. 
Among them, topical treatments are very unique, effective in the management of eye diseases and are called 
“Netra Kriyakalpa”. Netra Kriyakalpa have very fast action on the target tissues of eye. Anjana is a medicinal 
preparation which is applied on the lower palpebral conjunctiva or the cul-de-sac. Its active principles may 
be transferred to the interior of the eye according to their hydrophilicity and lipophilicity mainly through 
the conjunctiva and cornea by paracellular and transcelullar pathways respectively. pH, viscosity, tonicity, 
molecular size and molecular weight of the active ingredients are highly responsible for the absorption of 
Anjana. According to its form Anjana is of 3 types i.e. Gutika, Rasakriya and Churna. Gutika and Churna types 
of Anjana can be correlated with ophthalmic suspensions and Rasakriya type is with aqueous solutions/eye 
drops. Gutika and Curna Anjana have micro particles which may be deposited in the cul-de-sas and thereby 
increase the bioavailability to enhance ocular absorption. Anjana therapy may be highly beneficial in the 
anterior segment disorders because of the presence of several anatomical, biological and physiological 
ocular barriers. However it gives better results on the posterior segment disorders also. 
  KEYWORDS: Anjana, Netra Kriyakalpa, Hydrophilic, Lipophilic. 
INTRODUCTION 
 Shalakya Tantra is one of the eight specialties of 
Ashtanga Ayurveda which deals with diseases which occur 
above the clavicle specially the sensory organs i.e. Eyes, 
Nose, Ears and Tongue. Eyes hold special status among all 
the sense organs because good vision is crucial for social 
and intellectual development of human beings and the 
knowledge from direct observation (Pratyaksha pramana) 
can be achieved only by eyes. Other sense organs also 
depend on the eye sight for their accuracy as quoted by 
ancient sage Vagbhata.[1] He said that for a man without 
eyes this world is useless because day and night are same 
for them even if the other sensory organs are healthy. Thus 
Vagbhata recommended that all efforts should be 
performed to protect the eyes throughout the life. Hence 
authentic classics prescribed several preventive and 
curative measures to protect the eyes. Almost all the 
Acharyas prescribed several treatment procedures for the 
management of ophthalmic disorders such as systemic, 
surgical, para-surgical and local or topical treatments. 
Among these several types of treatment modalities local 
treatments are very specific, effective and unique to the 
eye diseases and called as “Netra Kriyakalpa”. It is similar 
as Panchakarma in Kayachikithsa. Netra Kriyakalpa have 
very fast action to the target tissues including posterior 
segment of the eye. 
 There are seven Netra Kriyakalpas namely Akshi 
Tarpana, Putapaka, Seka, Aschyotana, Anjana, Bidalaka and 
Pindi. The first 5 procedures were mentioned in Susruta 
Samhitha[2] and last two were prescribed only in 
Sharangadhara Samhitha[3] along with other 5 procedures.  
 Akshi tarpana – Give nourishment to eyes through 
oily preparations. 
 Putapaka – Same as Akshi Tarpana but drug should 
be prepared according to Putapaka preparation 
method. 
 Seka – Pour liquid medicinal preparations into closed 
eyes and more beneficial for acute conditions. 
 Aschyotana – Same as Seka but Aschyotana is poured 
into open eyes and it is the foremost procedure for all 
the eye diseases.  
 Anjana – Indicated as curative and preventive 
measure. It should be applied only in Dosha Pakva 
Avasta. 
 Bidalaka – Medicated paste is applied around the 
eyes except the eyelids in early stage of eye diseases. 
It is helpful as it increases the blood circulation to the 
eyes. 
 Pindi – Same as Bidalaka but medicinal paste is kept 
over whole eye including lashes. 
 Allopathic system of medicine also developed 
several ocular treatment modalities and can be divided 
into four main divisions as systemic administrations, 
periocular injections, intraocular injections and topical 
instillations. Topical instillations included eye drops, eye 
ointments, gels, ocuserts and soft contact lenses. These 
topical instillations can be correlated with Kriya Kalpas.  
 Eye drops – May be in the form of aqueous solutions 
or aqueous suspensions. It gives quick action and 
diluted immediately by tears. 
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 Eye ointments – Increases the bioavailability of the 
drug by increasing tissue contact time and by 
preventing dilution and quick absorption but cause 
blurred vision. 
 Gels – Have prolonged contact time and do not cause 
much blurred vision. 
 Suspensions - Dispersion of finely divided insoluble 
active pharmaceutical ingredients in an aqueous 
solvent consisting of a suitable suspending and 
dispersing agent which increases the bioavailability. 
 Ocuserts – Can be placed in the upper or lower fornix 
up to a week and allow drug to be released at a 
relatively constant rate. 
 Soft contact lenses – Very good for delivering higher 
concentrations of drugs in emergency treatment. 
 Among all these Kriyakalpas Anjana has unique 
therapeutic efficacy for several types of ophthalmic 
disorders and highly recommended as preventive measure 
of eye diseases in the Ayurvedic system of medicine. A 
number of ancient Acharyas prescribed Anjana therapy as 
daily regimen especially Sauvira Anjana (Animony 
sulphide) and Rasanjana (decoction of Berberista aristata – 
Daruharidra) mixed with bee honey as it eliminates Kapha 
Dosha from the eye because eyes have predominance of 
Pitta Dosha or Teja Mahabhoota for its proper functioning 
or clarity of vision.[4-6]  
 Apart from the Ayurveda the practice of Anjana 
was prevalent during Indu valley civilization for 
prevention of diseases as well as cosmetic purposes. 
Anjana is also mentioned in Atharvaveda however a 
detailed description is found in Sushrutha Samhita, 
Ashtanga Hridaya, Ashtanga Sangraha and Sharangadhara 
Samhita which are described its classification, form, 
dosage, method of application, indications and 
contraindications etc. “Anakthi thi Anjanam” is the 
definition of Anjana and word root is Anji because it gives 
moving, cleaning and clarity to eyes. [7] In this procedure a 
Lepa (semisolid or solid) is applied on the inner part of the 
lower eye lid from inner canthus (Kaneenika Sandhi) to 
outer canthus (Apanga Sandhi) with Anjana Shalaka.  
AIMS AND OBJECTIVES 
1. To review Anjana therapy according to the Ayurvedic 
point of view. 
2. To study the probable mode of action of Anjana 
according to modern point of view.  
TYPES OF ANJANA[8,9,10,11] 
 According to its form Anjana it is of 3 types i.e. 
Gutika (Pills), Rasakriya (Semisolid) and Churna (powder). 
Acharya Susruta and Vagbhata mentioned that the 
strength of Anjana increases in preceding order as Gutika, 
Rasakriya and Churna. However Acharya Bhavamishra 
mentioned that order somewhat differently as Rasakriya, 
Varti and Churna. Hence can be used Anjana according to 
the severity of the disease as Gutika, Rasakriya and Churna 
for the most severe, moderate and mild disorders 
respectively. 
 As per the action it is again three types namely 
Lekhana (sraping), Ropana (healing) and Prasadana 
(purifying). In Sharangadhara Samhita Snehana (oleation) 
and in Ashtanga Hridaya Drishti Prasadana (improve 
vision) type is mentioned instead of Prasadana Anjana in 
Susruta samhita. 
Table 1: Composition of Anjana 
Type of Anjana Composition Action 
Lekhana 
 
Tikta, Kashaya, Amla, Katu, Lavana 
Tastes Kshara, Tikshna Guna 
Drain out Doshas from eye lids, vessels, sacs, Srotas 
& Sringataka Marma through mouth, nostrils & eyes 
Ropana Kashaya, Tikta + ghee/oil Healing, improves the colour and visual acuity 
Prasadana/Snehana/ 
Drishti Prasadana 
Madhura + ghee/oil Pacifying the Doshas in vision, oleation 
INDICATIONS OF ANJANA 
 Anjana should be performed when symptoms of doshas are manifested and located only in the eyes and after the 
purification of body. Body should be purified by Panchakarma procedures i.e. Nasya, Virechana, Vasti, Raktamokshana. 
Table 2: Indications of Anjana 
Indication Susruta samhita[12] Ashtangahridaya[13] Sharangadhara 
Samhita[14] 
Bhavaprakasha[15] 
After the Dosha manifested +    
Dosha located only in eye + +   
After body purification + +   
Dosha become Pakva   + + + 
Slight oedema in eye  +   
Severe itching in eye  +   
Sliminess of eye  +   
In thick eye secretions  +   
Vataja, Pittaja, Kaphaja & 
Raktaja disorders 
 +   
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 In addition to above indications Sharangadhara 
samhita[14] and Bhavaprakasha[16] recommended that the 
time of Anjana procedure according to the seasons.  
 In afternoon – Hemanta and Sisira In morning – 
Grishma In evening – Sarath Any time – Vasanta In rainy 
season Anjana should not be too much of cold or too much 
of hot. 
 Not only the seasonal recommendations; ancient 
Acharyas mentioned the time of Anjana application within 
the day also. Almost all of them recommended Anjana 
therapy only in the morning, evening and night neither in 
day time.[5,17] Preferably in the morning Lekana type of 
Anjana for Kaphaja diseases, in evening Snehana type for 
Vataja diseases and in the night Prasadana type for Pittaja 
diseases.[18]  
Contraindications for Anjana[19,20,21] 
 Anjana process is contraindicated in those 
suffering from fatigue, Udavarta, excessive lacrimation, 
alcoholic, anger, fear, fever (especially early stage of fever), 
suppression of natural urges and disorders of head as it 
causes redness-discomfort-diminish of vision-discharge-
pain in eyes. Also it should not be applied during the 
period of less sleep (causes incapability in function), in 
windy days (damage the visual acuity), on exposure to 
dust and smoke (causes redness of eyes), in the presence 
of eye discharge and Adhimantha-defective vision with 
pain (produces congestion and pain), just after the Nasya, 
Vamana and Virechana procedures (produces congestion 
and pain), in headache (causes disorders in the head), after 
a head bath, in excessive cold days and before sunrise (due 
to firmness of Doshas), during indigestion (obstructs the 
channels-Srotas) and beginning of impulse of Dosha. 
Especially these contraindications are recommended for 
Lekhana Anjana. 
 Apart from above contraindications Acharya 
Bhavamishra advised that it should not be performed in 
excessively cold-hot-breezy days. If performed it will 
causes thickness, redness blindness due to a aggravation of 
respected Doshas and disturbs the sound sleep.[15]  
Dosage of Anjana 
Table 3: Anjana Dosage as Per the Susruta Samhitha[22] 
Type of Anjana Lekhana Prasadhana  Ropana 
Gutika 1 Harenu 1 1/2 Harenu 2 Harenu 
Raskriya 1 Harenu 1 1/2 Harenu 2 Harenu 
Churna 2 Shalaka 3 Shalaka 4 Shalaka 
Note – Hareṇu is a Sanskrit technical word translating to 
“black cardamom”. It is also known by the name Hareṇuka. 
The botanical name is Vitex agnus-castu, and is commonly 
known in English as “vitex”, “chaste tree”, “chasteberry”.[23]  
As per the Sharangadhara Samhitha[24],  
Gutikanjana – According to the potency of raw materials 
Tikshna (high in potency) - 1 Harenu  
Madhyama (moderate in potency) - 1 1/2 Harenu  
Mrudu (mild in potency)- 2 Harenu  
Rasakriyanjana – According to the quantity of drug 
Uttama matra - 3 Vidanga  
Madhyama matra - 2 Vidanga  
Heena matra - 1 Vidanga 
Note: The meaning of Vidanga is a seed of Embelia ribes 
which is also known as false black pepper. 
Churnanjana – According to the action of drug 
Virechana Karma - 2 Shalakas  
Mrudu Karma - 3 Shalakas  
Snehana Karma - 4 Shalakas 
How to Perform Anjana Therapy[25,26] 
 Almost all the Acharyas prescribed it should be 
applied from the inner canthus to the outer canthus and 
vice-versa on the inner part of the eye lid or on the 
palpebral conjunctiva by using an Anjana Shalaka or 
physician’s finger. But here they have not mentioned the 
exact eye lid ie. upper or lower. Hence it can be taken as 
lower palpebral conjunctiva or cul-de-sac because it 
provided enough space to application and easy to perform. 
Susruta and Vagbhata described the procedure in detailed. 
Physician should be hold the two eye lids separately with 
his left hand (with the thumb and index finger) and hold 
the Anjana Shalaka by his right hand. It can be applied 
several times which provides proper application and 
increases the bio availability. But it should not be applied 
excessively or with painful manipulation. Patient is asked 
to move the eyeballs upwards and rotate slowly which 
allows the medicine to spread over the eye. Also eyelids be 
moved slightly by eye massaging this might be helpful for 
increase absorption by enhancing blood circulation around 
the eyes. But blinking, squeezing or washing of the lids 
should not be done till the properly performed Anjana 
features appeared.  
 Eye wash with water or suitable medicines for the 
respective disease, Doshas or season is recommended as 
Paschat Karma. Otherwise remaining medicines may 
vitiate the Doshas and give rise to the disease and caused 
itching sensation. To control these Dhumpana (medicinal 
smoking) can be performed. Pratyanjana (restorative 
collyrium) can be applied to control the irritation as well.  
 However Anjana which are used as therapeutics 
should not be very strong or very weak in potency, very 
little or very large in quantity, too thin or too thick in 
consistency, very rough and too hot.[27] 
Samyakyoga, Atiyoga and Heenayoga Features of 
Anjana[28] 
 Acharya Susrutha explained well about the 
Samyakyoga, Atiyoga and Heenayoga features of Lekhana, 
Prasadana and Ropana types of Anjana. Features of 
properly performed Anjana therapy are known as 
Samyakyoga Lakshana whereas excessively performed 
features are known as Atiyoga Lakshana. Inadequately 
performed features are called Heenayoga Lakshana. 
 Samyakyoga Lakshana of Lekhana Anjana are non 
sliminess of eyes, lightness of eyes, non discharging, 
swift in action, cleanliness of eyes and subsided the 
complications. 
 Atiyoga Lakshana of Lekhana Anjana are deviation of 
eyes, hardness of eyes, discolouration of eyes, 
drooping of eyes, roughness of eyes and excessive 
discharge. All of the above characteristics features 
cause Vata Dosha vitiation which must be managed 
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Santarpana Karma (Saturation) along with other Vata 
alleviating measures.  
 In inadequately performed Lekhana Anjana Doshas 
get more aggravated. This should be corrected by 
performing Dhumpana (medicinal smoking), Nasya 
(Snuffing) and Anjana therapy. 
 In properly performed Prasadana Anjana eyes attain 
unctuousness-proper colour and strength, 
cheerfulness of eyes, cleanliness of eyes and it 
functions perfectly.  
 If Prasadana Anjana is applied excessively, eye is 
affected with some mild disorders. In this case rough 
drugs should be used to pacifying Dosha. 
 Prasadana Anjana applied deficiently becomes 
useless. 
 All the features such as Samyakyoga, Atiyoga and 
Heenayoga of Ropana Anjana are same as Prasadana 
Anjana but results moderately.  
Hence for the better efficacy proper dose of Anjana must 
be advised. 
Materials Used in Anjana Karma 
 Anjana shalaka 
 Anjana patra  
 Drugs are the essential materials for Anjana Karma.  
Anjana Shalaka[29,30,31] 
Anjana Shalaka or collyrium probe is a cylindrical 
rod with 8 Angulas in length which is made of metals, 
stones or horns of animals and ends should be bluntly 
pointed like a flower bud. 
Anjana Patra[32] 
 The container used for the storage of Anjana is 
known as Anjana Patra. The material should be taken 
according to the medicinal property of the drug. It is 
further advised the Anjana Shalaka also can be made 
accordingly.  
Routes of Ocular Drug Administration and Drug 
Absorption in Relation to Anjana 
 Drugs can be administered to eye by various routs 
such as topical, periocular, intraocular and systemic. 
Periocular route includes subconjunctival, sub-Tenon’s, 
peribulbar and retrobulbar whereas intraocular route is 
consists of intracameral and intravitreal types. Among all 
these routes topical route is the most flavored route 
specially for the anterior segment and ocular surface 
disorders. However the route should be selected according 
to the target ocular tissue.  
 Anjana is a medicinal preparation which applies 
on the lower palpebral conjunctiva or the cul-de-sac. 
Therefore this can be taken as topical type of ocular drug 
administration. The major tasks of developing topical 
ocular drugs are increase the bioavailability and control or 
constant release of drug delivery. Because precorneal 
factors, anatomical barriers and systemic absorption are 
negatively affect the bioavailability. 
 Mainly affected precorneal factors include 
solution drainage, blinking, tear film, tear turn over and 
induced lacrimation.[33] Tear film offers the first resistance 
due to its high turnover rate. Lacrimal turnover rate is 
about 1 μl /min. Thus excess volume is flown to the 
nasolacrimal duct within a few minutes.[34] Mucin present 
in the tear film plays a protective role by forming a 
hydrophilic layer that moves over the glycocalyx of the 
ocular surface and clears debris and pathogens including 
ocular drugs also.[35] Human tear volume is estimated to be 
7 μl. The cul-de-sac can transiently contain around 30 μl of 
the administered eye drop. However, tear film displays a 
rapid restoration time of 2–3 min, and most of the topically 
administered solutions are washed out within just 15–30 s 
after its instillation.35 Blinking of eyes promote the 
drainage of instilled ocular drugs through the nasolacrimal 
duct. Each blinking removes about 2 µl of fluid from the 
cul-de-sac.[36] Due to the spontaneous tear flow instilled 
drugs are completely lost from the cul-de-sac in about 5 
minutes and 80% of the drug lost through the nasolacrimal 
drainage.[37] Considering all the precorneal factors, contact 
time with the absorptive membranes is lower, which is 
considered to be the primary reason for less than 5% of 
the applied dose reaching the intraocular tissues.[36] 
 Eye is an extremely accessible organ foreign 
material. When considering anatomical barriers cornea 
and conjunctiva act as main barriers which are the most 
superficial layers of the eye. Cornea has five layers among 
them main three layers responsible for the drug 
transportation namely; outer lipophilic epithelium and 
Bowmen’s membrane (which acts as a barrier for 
hydrophilics), middle hydrophilic stroma (which acts as 
barrier for lipophilics) and inner less lipophilic 
endothelium (which forms barrier to hydrophilics).[37] The 
tight junctions in the most superficial layer of corneal 
epithelium limit the paracellular drug permeation.[38] It 
serve as selective barrier for the small molecules and 
completely prevent the diffusion of large molecules.[37] 
However lipophilic drugs have higher permeability than 
hydrophilic drugs via the corneal epithelium.[39] Despite 
the high permeability of liphophilic drugs corneal pores in 
between the tight junctions allow to penetrate small 
hydrophilic molecules (<3nm).[37] Corneal stroma is 
hydrophilic in nature and a relatively open structure. 
Molecular weight up to 500,000 kd and hydrophilics can 
pass through it and it is comparatively act as a barrier for 
lipophilics.[37] Endothelium offers little resistance for the 
drugs due to the presence of gap junctions. Due to biphasic 
solubility nature of cornea both the liphophilic and 
hydrophilic molecules can pass through it. Especially 
liphophilics travels through the transcellular pathway and 
hydrophilic molecules from the paracellular pathway 
(through the tight junctions of epithelium) both by 
diffusion.[37] Thus the transcorneal permeation is the main 
route of drug entrance from lacrimal fluid to the aqueous 
humour. From the aqueous homour drugs can easily enter 
to the ciliary body and iris where the drug may bind to the 
melanin. This forms a reservoir which is released drugs 
gradually to the surrounding cells which prolonging the 
drug activity.[40]  
 The superficial layer of the conjunctival 
epithelium has tight junctions which are act as the main 
barrier for the drug penetration. In here also lipophilic 
drugs can diffuse through transcellular pathway and 
hydrophilic drugs passage through the paracellular 
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pathway.[37] The conjunctiva is more permeable than the 
cornea and its surface area is 20 times greater than that of 
cornea. Thus its permeability to hydrophilic drugs is 
higher than that of cornea and molecular weight 20,000-
40,000 kd can pass through the conjunctiva.[41,42,43] 
Conjunctiva is a highly vascularised structure; hence it is a 
major route for systemic drug absorption after topical 
instillation.[44] This systemic absorption reduces the 
bioavailability and drug transportation to the target ocular 
tissue. Not only the cornea and conjunctiva; sclera also 
plays an important role on the drug absorption. However it 
is more permeable to lager molecules than conjunctiva and 
cornea.[45] It is poorly vascularized and consists mainly 
collagen and mucopolysaccharides through which drugs 
can diffuse to the vitreus.  
 Another way of bioavailability reduction is 
systemic absorption. Drugs can reach the systemic 
circulation after topical ocular delivery by several routes 
such as through the aqueous humor, ciliary body, iris, 
eyelid margins and especially via the nasal mucosa. 
Systemic absorbed drugs have to cross the blood ocular 
barriers to reach the target ocular tissue and have less 
chance of reaching ocular tissues. Regarding Anjana 
therapy considerable amount of drug may pass to the 
nasolacrimal duct due to increased lacrimation and then 
undergo to systemic absorption. In addition to 
nasolacrimal drainage by tear evaporation, drug binding to 
proteins in tear, drug metabolism by tear enzymes also 
responsible for reduce the drug absorption amount.  
 Anjana therapy as a kind of topical administration 
may be highly activated in the anterior segment of the eye 
which is up to the crystalline lens. Its active principles may 
be transfer to the interior of the eye according to their 
hydrophilicity and lipophilicity mainly through the 
conjunctiva and cornea respectively. 
PHARMACOKINETICS OF ANJANA 
 The process of drug uptake by the body, 
distribution to the target tissues, its biotransformation or 
its metabolism and the method of excretion from the body 
is known as pharmacokinetics of a drug. The main drug 
absorptions methods to eye is consists of passive diffusion, 
carrier mediated transport (facilitated diffusion and active 
transport) and endocytosis.[37] Passive diffusion refers to 
the process of movement of drug molecules across the 
biological barrier accordion to its concentration. It does 
not need energy and this is the primary mode of drug 
transport across the ocular surface. Passive diffusion also 
depends upon the degree of ionization (pH) and lipid 
solubility of the drug.[37] Also some drugs are transported 
cross the biological barriers by carrier mediate transport. 
In this method carrier molecules presented on the 
membrane surface forms a complex with the drug 
molecule. Carrier mediated diffusion of molecules along 
the concentration gradient is known as facilitated diffusion 
which does not require energy. Its rate of diffusion 
depends upon the ability of drug molecules to bind with 
the carrier and the availability of carriers.[37] Active 
transport refers to carrier mediated drug transport against 
the concentration gradient; it requires energy. Uptake of 
drug molecules by plasma membrane derived vesicles is 
named as endocytosis. Therefore all the topical 
instillations including Anjana transport cross the 
conjunctiva, cornea, sclera, iris, ciliary body, lens ect via 
the above mentioned drug absorption methods.  
 According to its form Anjana is 3 types i.e. Gutika, 
Rasakriya and Churna. Hence the Gutika and Churna types 
of Anjana can be correlated with ophthalmic suspensions 
and Rasakriya type is with aqueous solutions/eye drops. 
Rasakriya Anjana is completely soluble without any 
sedimentation hence it can be compared with modern eye 
drops. Because of its solubility and micro molecules it can 
be rapidly and easily absorbed but its drainage out from 
the cul-de-sac is rapid. Thus its bioavailability and rate of 
ocular absorption is comparatively lesser than the other 
two types of Anjana forms. Gutika and Churna types of 
Anjana have sedimentated micro particle; so that these 
types can be correlated with ophthalmic suspensions. 
Suspensions are non-invasive ocular topical drop drug 
carrier systems which can be defined as dispersion of 
finely divided insoluble active pharmacological ingredients 
in an aqueous solvent consisting of a suitable suspending 
and dispersing agent. Suspension particles retain in cul-de-
sac and thereby improve drug contact time and duration of 
action relative to drug solution. Duration of drug action for 
suspension depends upon the particle size of the drug.[46] 
Because suspensions contain micronized drug molecules 
most preferably less than 10 µm in diameter.[37] Therefore 
particle size of active agent plays a key role because 
sedimentation rate, agglomeration and resuspendability 
are totally affected by the size of particles. Suspensions’ 
drug delivery system takes place in two phases i.e. rapid 
and slow. Small particle size promotes fast dissolution and 
fast absorption but these small particles tend to easily 
drain out from the cul-de-sac which may results decrease 
the bioavailability and absorption. Mean while lager 
particle size helps retain particles for longer time and slow 
drug dissolution.[37] Thus an optimal particle size is 
expected to result in optimum drug activity. 
 In case of Anjana preparation Gutica and Churna 
types prepared by dry milling, grinding and micro 
pulverization which are the processes help in getting 
optimal particle size but still it has not standardized the 
best particle size. Thus it can be taken as <10 µm because 
that size generally minimizes the ocular irritation. As per 
the modern pharmacology ophthalmic suspensions should 
be formulate according to the following steps with proper 
sterilization method.[47] 
1. Preparation of a dispersion of the drug 
2. Preparation of the structured vehicle, followed by 
addition of the drug dispersion 
3. Addition of the other adjuncts – preservatives, 
wetting agents, suspending agents ect. 
4. Homogenization 
 All the above 4 steps are followed by Anjana 
process except the adding specific preservatives because 
drugs itself act as preservatives and most of the time 
freshly prepared drugs are use in Ayurveda. Meanwhile 
bee honey, ghee, breast milk and some of the medicinal 
fresh juices commonly use as vehicles and wetting agents. 
Hence it should be carefully monitored for the proper 
maintenance of sterilization of the drug. Moreover 
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optimum pH, tonisity and viscosity of the preparation are 
play a significant role on its bioavailability and amount and 
rate of absorption. 
PROBABLE MODE OF ACTION OF ANJANA 
 Once applied an Anjana it acts as a foreign body to 
ocular surface. Hence eye gets reflex secretion in response 
to foreign particles on cornea and conjunctiva. Due to that 
considerable amount of drug washes out from the eye by 
weeping and another major portion may drainage to the 
nasolacrimal duct (NLD). Apart from these another part 
may be eliminated from the ocular surface by evaporation 
(mainly Rasakriya Anjana), metabolization by tear 
enzymes and get in contact with tear proteins. Finally it 
mains in the cul-de-sac a very less amount of Anjana for 
the ocular absorption; meanwhile the portion drainage to 
the NLD may absorb to the systemic circulation by nasal-
laryngeal and oral mucosa. On the other hand Gutika and 
Churna Anjana have micro particles which may be 
deposited in the cul-de-sac and thereby increase the 
bioavailability to enhance ocular absorption.  
  The ocular absorption of Anjana may initiate 
though the conjunctiva and cornea. Mainly lipophilic active 
ingredients may absorb through the cornea by 
transcellular pathway and hyrophilics from the 
conjunctiva by paracellular pathway. This ocular 
absorption may be depend on the passive diffusion, carrier 
mediated transport (facilitated diffusion and active 
transport) and endocytosis. Also pH, viscosity, tonicity and 
most importantly molecular size and molecular weight of 
the active ingredients play a major role of the same. Once it 
crosses the conjunctiva (mainly hydrophilics); the sclera is 
more permeable and it allows drugs to penetrate the other 
interior structures of the eye i.e. ciliary body, iris, aqueous 
houmer, lens, vitreous ect. But due to high vascularization 
of conjunctiva, ciliary body and iris considerable amount of 
drug may be enter to the systemic circulation again. The 
drugs pass though the corneal epithelium (mainly 
lipophilics) directly goes to the aqueous humour and 
distribute to the other ocular tissues. However some of the 
drugs coming to the aqueous humour either via cornea or 
conjunctiva are undergo to metabolization by the enzymes 
present in the aqueous. 
 Considering all these factors it can be said that 
Anjana therapy may be highly activated in the anterior 
segment of the eye because of the presence of several 
anatomical, biological and physiological ocular barriers. 
But in the system of Ayurveda pharmacological actions of a 
drug may explain according to its pharmacological 
properties which are included Rasa, Guna, Virya, Vipaka 
and Prabhava. These qualitative qualities are still not 
explained and interpritated in accordance to the modern 
science. Hence as per the view of Ayurveda these 
qualitative measures may act on the posterior segment of 
the eye.  
DISCUSSION AND CONCLUSSION  
 Considering all of above discussed factors Anjana 
therapy is a holistic, well developed method of topical 
ocular drug administration which is described in detail 
with its indications, contraindications, application method, 
pre and post procedure measures, dosage forms and even 
proper storage advices in authentic texts. It can be taken as 
a further development of Ashyotana due to its increased 
bioavailability on the ocular surface than the Ashyotana. 
Not only that ancient Achryas advised some processes to 
overcome some practical difficulties of Anjana therapy too 
such as Anjana should be applied from medial canthus to 
lateral canthus and vice- versa; which increases 
bioavailability, just after the application the patient is 
asked to move the eyeballs upwards and rotate slowly 
which allows the medicine to spread over the eye, eyelids 
should be moved slightly by eye massaging with close eyes 
this might be helpful for increase absorption by limiting 
nasolcrimal drainage. However the exact mode of action of 
the Anjana therapy is still not proved by any experimental 
studies. Hence now it is high time to prove our ancient 
knowledge in accordance to modern point of view. 
 High ocular irritation and less contact time are the 
main problems in Anjana therapy. Ocular irritation can be 
minimize by using the optimal particle size (<10 µm) and 
using pH between 6.5 to 7.6; which is the pH value of 
normal tears. Meanwhile bioavailability can be increase by 
using optimal viscosity and tonicity. The optimal viscosity 
for ophthalmic preparation is 12-15cp and optima tonicity 
is 266-445mOsm/kg. Normally instilled drugs completely 
disappear from the cul-de-sac in about 5 min specially eye 
drops. Thus if the second drop is applied 5 min after the 1st 
drop then no washout effect occurs on the 1st drop. Hence 
this theory can be applied for the Rasakriya Anjana for 
optimal results; however for the Churna Anjana and Gutika 
Anjana have higher bioavailability itself.  
 Most of the modern topical ocular preparations 
are not able to reach up to the posterior segment. But 
Anjana is a good, simple, easy and effective treatment 
modality for treating both the anterior and posterior 
segment disorders of the eye which is being practiced 
more than 5000 years. Finally it can be concluded that 
Anjana is an ideal remedy for various types of ophthalmic 
disorders; which can be used as preventive as well as 
curative measure.  
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Figure 1: Schematic diagram of probable mode of action of Anjana therapy 
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